Mineralocorticoid receptor antagonists: The evolution of utility and pharmacology
- 1 April 2000
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 57 (4) , 1408-1411
- https://doi.org/10.1046/j.1523-1755.2000.00983.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Production of Aldosterone in Isolated Rat Blood VesselsHypertension, 1995
- Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension.Hypertension, 1994
- Aldosterone ActionAnnual Review of Physiology, 1993
- Reactive and reparative myocardial fibrosis in arterial hypertension in the ratCardiovascular Research, 1992
- HIGH AFFINITY ALDOSTERONE BINDING SITES (TYPE I RECEPTORS) IN RAT HEARTClinical and Experimental Pharmacology and Physiology, 1987
- Comparison of Spironolactone Tablet Dosage Forms in Healthy HumansJournal of Pharmaceutical Sciences, 1974
- Plasma Levels of Spirolactones in the DogJournal of Pharmaceutical Sciences, 1972
- Disposition of Tritium-Labeled Spirolactones in the DogJournal of Pharmaceutical Sciences, 1972
- Pharmacokinetic and Metabolic Fate of Potassium Canrenoate (SC-14266) in ManJournal of Pharmaceutical Sciences, 1971